DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986251
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-986251
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C30H29F8NO5S
Molecular Weight:
667.61
AlogP:
6.47
PSA:
91.75
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CYT-500 177LU
1
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms
Glutamate carboxypeptidase II binding agent
CYT-500 177LU
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BAKUCHIOL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BAKUCHIOL
×
Maximum Phase:
1
First Approval:
None
UNII:
OT12HJU3AR
Molecule Type:
Small molecule
Molecular Formula:
C18H24O
Molecular Weight:
256.39
AlogP:
5.34
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BTA-9881
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Unknown
BTA-9881
×
Maximum Phase:
1
First Approval:
None
UNII:
9VR1J6U4XG
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClN4O2
Molecular Weight:
390.83
AlogP:
2.94
PSA:
66.4
HBD:
0.0
HBA:
#RotB:
2.0
Source:
FILANESIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Leukemia, Plasma Cell; Myelodysplastic Syndromes; Neoplasms; Multiple Myeloma
Kinesin-like protein 1 inhibitor
FILANESIB
×
Maximum Phase:
1
First Approval:
None
UNII:
8A49OSO368
Molecule Type:
Small molecule
Molecular Formula:
C20H22F2N4O2S
Molecular Weight:
420.49
AlogP:
3.88
PSA:
71.16
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AVIZAKIMAB
1
Antibody
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Unknown
AVIZAKIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
4H3BBE5WVK
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHIP
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PHIP
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOTULISM ANTITOXIN BIVALENT (EQUINE) TYPES A AND B
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BOTULISM ANTITOXIN BIVALENT (EQUINE) TYPES A AND B
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
123-I-MIP-1072
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
123-I-MIP-1072
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIMAGLERMIN ALFA
1
Protein
Investigational
Unknown
Unknown
Heart Failure
Unknown
CIMAGLERMIN ALFA
×
Maximum Phase:
1
First Approval:
None
UNII:
B2A4EZ9I83
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TIBULIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Sjogren's Syndrome
Interleukin 17A inhibitor
TIBULIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
42HQ15W1ZF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
JMT-101
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms
Unknown
JMT-101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PINOMETOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
PINOMETOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
8V9YR09EF3
Molecule Type:
Small molecule
Molecular Formula:
C30H42N8O3
Molecular Weight:
562.72
AlogP:
3.32
PSA:
151.23
HBD:
4.0
HBA:
#RotB:
8.0
Source:
E7107
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
E7107
×
Maximum Phase:
1
First Approval:
None
UNII:
R60DZX1E2N
Molecule Type:
Small molecule
Molecular Formula:
C40H66N2O9
Molecular Weight:
718.97
AlogP:
5.05
PSA:
152.53
HBD:
4.0
HBA:
#RotB:
10.0
Source:
SAPOSIN C (NON-GLYCOSYLATED)
1
Unknown
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Neoplasms
Unknown
SAPOSIN C (NON-GLYCOSYLATED)
×
Maximum Phase:
1
First Approval:
None
UNII:
2N62LTC861
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALEPLASININ
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Plasminogen activator inhibitor-1 inhibitor
ALEPLASININ
×
Maximum Phase:
1
First Approval:
None
UNII:
LL56J87F3X
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3
Molecular Weight:
425.53
AlogP:
6.23
PSA:
59.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
MEPHEDRONE
1
Small molecule
Investigational
Unknown
Unknown
Amphetamine-Related Disorders
Unknown
MEPHEDRONE
×
Maximum Phase:
1
First Approval:
None
UNII:
8BA8T27317
Molecule Type:
Small molecule
Molecular Formula:
C11H15NO
Molecular Weight:
177.25
AlogP:
1.79
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
3.0
Source:
INCAGN-02385
1
Unknown
Investigational
Unknown
Unknown
Melanoma
Unknown
INCAGN-02385
×
Maximum Phase:
1
First Approval:
None
UNII:
Z0A08C63DF
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DELANZOMIB
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Multiple Myeloma
Unknown
DELANZOMIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6IF28942WO
Molecule Type:
Small molecule
Molecular Formula:
C21H28BN3O5
Molecular Weight:
413.28
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SALVINORIN A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SALVINORIN A
×
Maximum Phase:
1
First Approval:
None
UNII:
T56W91NG6J
Molecule Type:
Small molecule
Molecular Formula:
C23H28O8
Molecular Weight:
432.47
AlogP:
3.0
PSA:
109.11
HBD:
0.0
HBA:
#RotB:
3.0
Source:
VORUCICLIB
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma; Neoplasms
Cyclin-dependent kinase 4 inhibitor
VORUCICLIB
×
Maximum Phase:
1
First Approval:
None
UNII:
W66XP666AM
Molecule Type:
Small molecule
Molecular Formula:
C22H19ClF3NO5
Molecular Weight:
469.84
AlogP:
4.32
PSA:
94.14
HBD:
3.0
HBA:
#RotB:
3.0
Source:
CHO-H01
1
Unknown
Investigational
Unknown
Unknown
Lymphoma, Follicular
Unknown
CHO-H01
×
Maximum Phase:
1
First Approval:
None
UNII:
OJ72N0B4UC
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHA-793887
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase inhibitor
PHA-793887
×
Maximum Phase:
1
First Approval:
None
UNII:
MKS45S912B
Molecule Type:
Small molecule
Molecular Formula:
C19H31N5O2
Molecular Weight:
361.49
AlogP:
2.31
PSA:
81.33
HBD:
2.0
HBA:
#RotB:
4.0
Source:
OCTANOIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Essential Tremor; Gallbladder Neoplasms; Leukemia, Myeloid, Acute; Small Cell Lung Carcinoma; Myelodysplastic Syndromes; Sarcoma, Myeloid
Unknown
OCTANOIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
OBL58JN025
Molecule Type:
Small molecule
Molecular Formula:
C8H16O2
Molecular Weight:
144.21
AlogP:
2.43
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
6.0
Source:
GSK-369796
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
GSK-369796
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H22ClN3O
Molecular Weight:
355.87
AlogP:
5.23
PSA:
57.18
HBD:
3.0
HBA:
#RotB:
4.0
Source:
ADCT-602
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ADCT-602
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GAMMA-AMINOBUTYRIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Epilepsy
Unknown
GAMMA-AMINOBUTYRIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
2ACZ6IPC6I
Molecule Type:
Small molecule
Molecular Formula:
C4H9NO2
Molecular Weight:
103.12
AlogP:
-0.19
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MFGR1877S
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MFGR1877S
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
R-1487
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
R-1487
×
Maximum Phase:
1
First Approval:
None
UNII:
IO0DCY55NQ
Molecule Type:
Small molecule
Molecular Formula:
C19H18F2N4O3
Molecular Weight:
388.37
AlogP:
2.99
PSA:
78.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C2H8Cl3NO2Te
Molecular Weight:
312.05
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
JNJ-42396302
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
JNJ-42396302
×
Maximum Phase:
1
First Approval:
None
UNII:
P5M4972608
Molecule Type:
Small molecule
Molecular Formula:
C19H23N5O2
Molecular Weight:
353.43
AlogP:
2.13
PSA:
64.78
HBD:
0.0
HBA:
#RotB:
5.0
Source:
NACUBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Gram-Negative Bacterial Infections; Kidney Diseases; Urinary Tract Infections
Unknown
NACUBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
832O37V7MZ
Molecule Type:
Small molecule
Molecular Formula:
C9H16N4O7S
Molecular Weight:
324.32
AlogP:
-2.0
PSA:
151.5
HBD:
3.0
HBA:
#RotB:
6.0
Source:
AZD-5312
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
AZD-5312
×
Maximum Phase:
1
First Approval:
None
UNII:
3S31QX1Q6J
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
77
78
79
80
81
82
83
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA